ArticleThe AAPS journal2020

Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit.

Duxin SunPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.